{
  "experiment_id": "36a348063a75b6d9e456c1950eb84501",
  "task_name": "broadening_of_narrow_synonyms",
  "task_hash": "a2c885aa2a82bb5b150f213062bbeb89",
  "model_id": "us.amazon.nova-premier-v1:0",
  "system_instructions": "_No response_",
  "temperature": 0.0,
  "thinking": false,
  "timestamp": "2025-11-13T18:44:59.781094",
  "task_result": {
    "task_name": "broadening_of_narrow_synonyms",
    "num_samples": 10,
    "results": [
      {
        "sample_index": 0,
        "input": {
          "diagnosis": "Neurofibromatosis type 1 microdeletion syndrome",
          "assay": "clinical whole-exome sequencing",
          "tumorType": "Plexiform neurofibroma (morphologic abnormality)"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Plexiform Neurofibroma\"\n}\n```\n\n**Corrections Made:**\n\n1. **Diagnosis**:\n   - Original: \"Neurofibromatosis type 1 microdeletion syndrome\"\n   - Corrected: \"Neurofibromatosis type 1\" (matches exact schema value)\n\n2. **Assay**:\n   - Original: \"clinical whole-exome sequencing\"\n   - Corrected: \"whole exome sequencing\" (removed \"clinical\" modifier to match schema value)\n\n3. **Tumor Type**:\n   - Original: \"Plexiform neurofibroma (morphologic abnormality)\"\n   - Corrected: \"Plexiform Neurofibroma\" (capitalization fixed and removed parenthetical descriptor to match schema value)\n\nThe corrections align all terms with the controlled vocabulary specified in the Target Schema while preserving their original meaning.",
          "model_id": "us.amazon.nova-premier-v1:0",
          "usage": {
            "inputTokens": 2647,
            "outputTokens": 229,
            "totalTokens": 2876
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "0ea6f14d-14ee-4e71-9130-8a9e33f3e65b",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 13 Nov 2025 18:44:28 GMT",
                "content-type": "application/json",
                "content-length": "1072",
                "connection": "keep-alive",
                "x-amzn-requestid": "0ea6f14d-14ee-4e71-9130-8a9e33f3e65b"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Plexiform Neurofibroma\"\n}\n```\n\n**Corrections Made:**\n\n1. **Diagnosis**:\n   - Original: \"Neurofibromatosis type 1 microdeletion syndrome\"\n   - Corrected: \"Neurofibromatosis type 1\" (matches exact schema value)\n\n2. **Assay**:\n   - Original: \"clinical whole-exome sequencing\"\n   - Corrected: \"whole exome sequencing\" (removed \"clinical\" modifier to match schema value)\n\n3. **Tumor Type**:\n   - Original: \"Plexiform neurofibroma (morphologic abnormality)\"\n   - Corrected: \"Plexiform Neurofibroma\" (capitalization fixed and removed parenthetical descriptor to match schema value)\n\nThe corrections align all terms with the controlled vocabulary specified in the Target Schema while preserving their original meaning."
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2647,
              "outputTokens": 229,
              "totalTokens": 2876
            },
            "metrics": {
              "latencyMs": 3108
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole exome sequencing",
          "tumorType": "Plexiform Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 2647,
          "output_tokens": 229,
          "total_tokens": 2876
        }
      },
      {
        "sample_index": 1,
        "input": {
          "diagnosis": "Neurofibromatosis type 1 with optic pathway glioma",
          "assay": "Illumina whole exome sequencing ",
          "tumorType": "malignant triton tumor"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Explanation:**\n\n1. **Diagnosis**:\n   - Original: \"Neurofibromatosis type 1 with optic pathway glioma\"\n   - Corrected: \"Neurofibromatosis type 1\"\n   - Reasoning: The schema specifies exact values, and \"Neurofibromatosis type 1\" is the closest match. The additional detail about optic pathway glioma is not part of the controlled vocabulary.\n\n2. **Assay**:\n   - Original: \"Illumina whole exome sequencing \"\n   - Corrected: \"whole exome sequencing\"\n   - Reasoning: The schema lists \"whole exome sequencing\" as the standardized term. Vendor-specific details like \"Illumina\" are omitted.\n\n3. **Tumor Type**:\n   - Original: \"malignant triton tumor\"\n   - Corrected: \"Malignant Peripheral Nerve Sheath Tumor\"\n   - Reasoning: \"Malignant Peripheral Nerve Sheath Tumor\" is the closest standardized term in the schema for a malignant nerve sheath tumor. \"Triton tumor\" is a subtype not listed, so the broader category is used.",
          "model_id": "us.amazon.nova-premier-v1:0",
          "usage": {
            "inputTokens": 2642,
            "outputTokens": 288,
            "totalTokens": 2930
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "0bb1547a-309a-44b6-ac29-7f16965a4553",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 13 Nov 2025 18:44:32 GMT",
                "content-type": "application/json",
                "content-length": "1335",
                "connection": "keep-alive",
                "x-amzn-requestid": "0bb1547a-309a-44b6-ac29-7f16965a4553"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Explanation:**\n\n1. **Diagnosis**:\n   - Original: \"Neurofibromatosis type 1 with optic pathway glioma\"\n   - Corrected: \"Neurofibromatosis type 1\"\n   - Reasoning: The schema specifies exact values, and \"Neurofibromatosis type 1\" is the closest match. The additional detail about optic pathway glioma is not part of the controlled vocabulary.\n\n2. **Assay**:\n   - Original: \"Illumina whole exome sequencing \"\n   - Corrected: \"whole exome sequencing\"\n   - Reasoning: The schema lists \"whole exome sequencing\" as the standardized term. Vendor-specific details like \"Illumina\" are omitted.\n\n3. **Tumor Type**:\n   - Original: \"malignant triton tumor\"\n   - Corrected: \"Malignant Peripheral Nerve Sheath Tumor\"\n   - Reasoning: \"Malignant Peripheral Nerve Sheath Tumor\" is the closest standardized term in the schema for a malignant nerve sheath tumor. \"Triton tumor\" is a subtype not listed, so the broader category is used."
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2642,
              "outputTokens": 288,
              "totalTokens": 2930
            },
            "metrics": {
              "latencyMs": 3812
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole exome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 2642,
          "output_tokens": 288,
          "total_tokens": 2930
        }
      },
      {
        "sample_index": 2,
        "input": {
          "diagnosis": "Watson Syndrome",
          "assay": "MGI whole genome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Unknown\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Explanation:**\n\n1. **Diagnosis**:\n   - The input value \"Watson Syndrome\" is not listed in the Target Schema's `diagnosis` enum. The closest match or standard equivalent is \"Unknown\" since it's not explicitly defined in the schema.\n\n2. **Assay**:\n   - The input value \"MGI whole genome sequencing\" contains a vendor-specific prefix (\"MGI\"). The standardized term in the schema is \"whole genome sequencing,\" so we remove the vendor prefix.\n\n3. **Tumor Type**:\n   - The input \"Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation\" is too specific. The schema includes \"Malignant Peripheral Nerve Sheath Tumor\" as the standardized term, so we simplify to match this value. The additional detail about mesenchymal differentiation isn't captured in the schema's enum values.",
          "model_id": "us.amazon.nova-premier-v1:0",
          "usage": {
            "inputTokens": 2639,
            "outputTokens": 232,
            "totalTokens": 2871
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "981e3d5c-3bd0-412a-ab63-9d8cd3cf9ed1",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 13 Nov 2025 18:44:36 GMT",
                "content-type": "application/json",
                "content-length": "1179",
                "connection": "keep-alive",
                "x-amzn-requestid": "981e3d5c-3bd0-412a-ab63-9d8cd3cf9ed1"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "```json\n{\n  \"diagnosis\": \"Unknown\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Explanation:**\n\n1. **Diagnosis**:\n   - The input value \"Watson Syndrome\" is not listed in the Target Schema's `diagnosis` enum. The closest match or standard equivalent is \"Unknown\" since it's not explicitly defined in the schema.\n\n2. **Assay**:\n   - The input value \"MGI whole genome sequencing\" contains a vendor-specific prefix (\"MGI\"). The standardized term in the schema is \"whole genome sequencing,\" so we remove the vendor prefix.\n\n3. **Tumor Type**:\n   - The input \"Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation\" is too specific. The schema includes \"Malignant Peripheral Nerve Sheath Tumor\" as the standardized term, so we simplify to match this value. The additional detail about mesenchymal differentiation isn't captured in the schema's enum values."
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2639,
              "outputTokens": 232,
              "totalTokens": 2871
            },
            "metrics": {
              "latencyMs": 4033
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole genome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 2639,
          "output_tokens": 232,
          "total_tokens": 2871
        }
      },
      {
        "sample_index": 3,
        "input": {
          "diagnosis": "neurofibromatosis, familial spinal",
          "assay": "open MRI",
          "tumorType": "unknown - no information available"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Explanation:**\n\n1. **Diagnosis**: The input \"neurofibromatosis, familial spinal\" was mapped to \"Neurofibromatosis type 1\" because familial spinal neurofibromatosis is a synonym for NF1, which is the closest match in the controlled terminology.\n\n2. **Assay**: \"open MRI\" was corrected to \"conventional MRI\" since open MRI is a type of conventional MRI, and the schema specifies \"conventional MRI\" as the standardized term.\n\n3. **Tumor Type**: \"unknown - no information available\" was standardized to \"Unknown\" to match the schema's controlled vocabulary for tumor types.",
          "model_id": "us.amazon.nova-premier-v1:0",
          "usage": {
            "inputTokens": 2633,
            "outputTokens": 182,
            "totalTokens": 2815
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "18a8476c-82d3-4e69-9b28-47e00c3b3e01",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 13 Nov 2025 18:44:38 GMT",
                "content-type": "application/json",
                "content-length": "935",
                "connection": "keep-alive",
                "x-amzn-requestid": "18a8476c-82d3-4e69-9b28-47e00c3b3e01"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Explanation:**\n\n1. **Diagnosis**: The input \"neurofibromatosis, familial spinal\" was mapped to \"Neurofibromatosis type 1\" because familial spinal neurofibromatosis is a synonym for NF1, which is the closest match in the controlled terminology.\n\n2. **Assay**: \"open MRI\" was corrected to \"conventional MRI\" since open MRI is a type of conventional MRI, and the schema specifies \"conventional MRI\" as the standardized term.\n\n3. **Tumor Type**: \"unknown - no information available\" was standardized to \"Unknown\" to match the schema's controlled vocabulary for tumor types."
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2633,
              "outputTokens": 182,
              "totalTokens": 2815
            },
            "metrics": {
              "latencyMs": 2705
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "conventional MRI",
          "tumorType": "Unknown"
        },
        "token_usage": {
          "input_tokens": 2633,
          "output_tokens": 182,
          "total_tokens": 2815
        }
      },
      {
        "sample_index": 4,
        "input": {
          "diagnosis": "Not Applicable",
          "assay": "immunohistochemistry of skin",
          "tumorType": "Cutaneous storiform neurofibroma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunohistochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Explanation:**\n\n1. **Diagnosis**: The input value \"Not Applicable\" matches the controlled terminology exactly, so no changes are needed.\n\n2. **Assay**: The input value \"immunohistochemistry of skin\" is narrowed by specifying \"of skin.\" The broader, standard term from the schema is simply \"immunohistochemistry.\"\n\n3. **Tumor Type**: The input value \"Cutaneous storiform neurofibroma\" uses \"storiform,\" which is a specific pattern not listed in the schema. The closest match in the schema is \"Cutaneous Neurofibroma,\" which is the broader category.\n\nThe corrected metadata adheres to the controlled terminology specified in the Target Schema.",
          "model_id": "us.amazon.nova-premier-v1:0",
          "usage": {
            "inputTokens": 2637,
            "outputTokens": 201,
            "totalTokens": 2838
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "5650cfa8-bd67-410c-9191-d7164a80b746",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 13 Nov 2025 18:44:42 GMT",
                "content-type": "application/json",
                "content-length": "1018",
                "connection": "keep-alive",
                "x-amzn-requestid": "5650cfa8-bd67-410c-9191-d7164a80b746"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "```json\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunohistochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Explanation:**\n\n1. **Diagnosis**: The input value \"Not Applicable\" matches the controlled terminology exactly, so no changes are needed.\n\n2. **Assay**: The input value \"immunohistochemistry of skin\" is narrowed by specifying \"of skin.\" The broader, standard term from the schema is simply \"immunohistochemistry.\"\n\n3. **Tumor Type**: The input value \"Cutaneous storiform neurofibroma\" uses \"storiform,\" which is a specific pattern not listed in the schema. The closest match in the schema is \"Cutaneous Neurofibroma,\" which is the broader category.\n\nThe corrected metadata adheres to the controlled terminology specified in the Target Schema."
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2637,
              "outputTokens": 201,
              "totalTokens": 2838
            },
            "metrics": {
              "latencyMs": 3173
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Not Applicable",
          "assay": "immunohistochemistry",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 2637,
          "output_tokens": 201,
          "total_tokens": 2838
        }
      },
      {
        "sample_index": 5,
        "input": {
          "diagnosis": "chromosome 17q11.2 deletion syndrome, 1.4Mb",
          "assay": "cell viability assay using Annexin V staining",
          "tumorType": "Pedunculated Cutaneous Neurofibroma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Explanation:**\n\n1. **Diagnosis:**\n   - The input term \"chromosome 17q11.2 deletion syndrome, 1.4Mb\" is a specific genetic description that corresponds to Neurofibromatosis type 1 (NF1). The Target Schema lists \"Neurofibromatosis type 1\" as the standardized term, so this is used.\n\n2. **Assay:**\n   - The input term \"cell viability assay using Annexin V staining\" is a specific method for assessing cell viability. The Target Schema includes \"cell viability assay\" as the broader, standardized term, so the specific staining method is omitted.\n\n3. **Tumor Type:**\n   - The input term \"Pedunculated Cutaneous Neurofibroma\" is a specific subtype of neurofibroma. The Target Schema lists \"Cutaneous Neurofibroma\" as the standardized term, which encompasses this specific subtype.\n\nThe corrected metadata adheres strictly to the controlled terminology provided in the Target Schema.",
          "model_id": "us.amazon.nova-premier-v1:0",
          "usage": {
            "inputTokens": 2656,
            "outputTokens": 265,
            "totalTokens": 2921
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "9bff21ca-fb29-4424-92e6-56556191f802",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 13 Nov 2025 18:44:45 GMT",
                "content-type": "application/json",
                "content-length": "1265",
                "connection": "keep-alive",
                "x-amzn-requestid": "9bff21ca-fb29-4424-92e6-56556191f802"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Explanation:**\n\n1. **Diagnosis:**\n   - The input term \"chromosome 17q11.2 deletion syndrome, 1.4Mb\" is a specific genetic description that corresponds to Neurofibromatosis type 1 (NF1). The Target Schema lists \"Neurofibromatosis type 1\" as the standardized term, so this is used.\n\n2. **Assay:**\n   - The input term \"cell viability assay using Annexin V staining\" is a specific method for assessing cell viability. The Target Schema includes \"cell viability assay\" as the broader, standardized term, so the specific staining method is omitted.\n\n3. **Tumor Type:**\n   - The input term \"Pedunculated Cutaneous Neurofibroma\" is a specific subtype of neurofibroma. The Target Schema lists \"Cutaneous Neurofibroma\" as the standardized term, which encompasses this specific subtype.\n\nThe corrected metadata adheres strictly to the controlled terminology provided in the Target Schema."
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2656,
              "outputTokens": 265,
              "totalTokens": 2921
            },
            "metrics": {
              "latencyMs": 3559
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "cell viability assay",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 2656,
          "output_tokens": 265,
          "total_tokens": 2921
        }
      },
      {
        "sample_index": 6,
        "input": {
          "diagnosis": "Neurofibromatosis type 1 with scoliosis",
          "assay": "anti-tag immunocytochemistry",
          "tumorType": "sessile cutaneous neurofibroma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"immunocytochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Explanation:**\n\n1. **Diagnosis**: The input \"Neurofibromatosis type 1 with scoliosis\" was narrowed to \"Neurofibromatosis type 1\" because scoliosis is a secondary condition not listed in the controlled terminology.\n\n2. **Assay**: \"anti-tag immunocytochemistry\" was generalized to \"immunocytochemistry\" since the specific tag detail isn't required by the schema.\n\n3. **Tumor Type**: \"sessile cutaneous neurofibroma\" was standardized to \"Cutaneous Neurofibroma,\" aligning with the schema's terminology and removing the descriptive modifier \"sessile.\"",
          "model_id": "us.amazon.nova-premier-v1:0",
          "usage": {
            "inputTokens": 2643,
            "outputTokens": 189,
            "totalTokens": 2832
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "65a8d687-bf1c-452f-9277-e476dd94c35b",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 13 Nov 2025 18:44:48 GMT",
                "content-type": "application/json",
                "content-length": "931",
                "connection": "keep-alive",
                "x-amzn-requestid": "65a8d687-bf1c-452f-9277-e476dd94c35b"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"immunocytochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Explanation:**\n\n1. **Diagnosis**: The input \"Neurofibromatosis type 1 with scoliosis\" was narrowed to \"Neurofibromatosis type 1\" because scoliosis is a secondary condition not listed in the controlled terminology.\n\n2. **Assay**: \"anti-tag immunocytochemistry\" was generalized to \"immunocytochemistry\" since the specific tag detail isn't required by the schema.\n\n3. **Tumor Type**: \"sessile cutaneous neurofibroma\" was standardized to \"Cutaneous Neurofibroma,\" aligning with the schema's terminology and removing the descriptive modifier \"sessile.\""
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2643,
              "outputTokens": 189,
              "totalTokens": 2832
            },
            "metrics": {
              "latencyMs": 2901
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "immunocytochemistry",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 2643,
          "output_tokens": 189,
          "total_tokens": 2832
        }
      },
      {
        "sample_index": 7,
        "input": {
          "diagnosis": "neurofibromatosis, peripheral type",
          "assay": "wide bore MRI",
          "tumorType": "no clear diagnosis"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Explanation:**\n\n1. **Diagnosis**: The input \"neurofibromatosis, peripheral type\" was mapped to \"Neurofibromatosis type 1\" from the controlled terminology, as it is the closest match for peripheral neurofibromatosis.\n\n2. **Assay**: \"wide bore MRI\" was replaced with \"conventional MRI\" since it's the standardized term in the schema for typical MRI techniques.\n\n3. **Tumor Type**: \"no clear diagnosis\" was mapped to \"Unknown\" because it indicates a lack of specific diagnosis, aligning with the schema's controlled vocabulary.",
          "model_id": "us.amazon.nova-premier-v1:0",
          "usage": {
            "inputTokens": 2632,
            "outputTokens": 173,
            "totalTokens": 2805
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "ac4e23c6-e541-46ad-bf14-694060d85165",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 13 Nov 2025 18:44:51 GMT",
                "content-type": "application/json",
                "content-length": "888",
                "connection": "keep-alive",
                "x-amzn-requestid": "ac4e23c6-e541-46ad-bf14-694060d85165"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Explanation:**\n\n1. **Diagnosis**: The input \"neurofibromatosis, peripheral type\" was mapped to \"Neurofibromatosis type 1\" from the controlled terminology, as it is the closest match for peripheral neurofibromatosis.\n\n2. **Assay**: \"wide bore MRI\" was replaced with \"conventional MRI\" since it's the standardized term in the schema for typical MRI techniques.\n\n3. **Tumor Type**: \"no clear diagnosis\" was mapped to \"Unknown\" because it indicates a lack of specific diagnosis, aligning with the schema's controlled vocabulary."
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2632,
              "outputTokens": 173,
              "totalTokens": 2805
            },
            "metrics": {
              "latencyMs": 3048
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "conventional MRI",
          "tumorType": "Unknown"
        },
        "token_usage": {
          "input_tokens": 2632,
          "output_tokens": 173,
          "total_tokens": 2805
        }
      },
      {
        "sample_index": 8,
        "input": {
          "diagnosis": "acoustic neurofibromatosis",
          "assay": "RNA-seq with ribosomal RNA depletion",
          "tumorType": "Acoustic neuroma of left vestibular nerve"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"NF2-related schwannomatosis\",\n  \"assay\": \"RNA-seq\",\n  \"tumorType\": \"Vestibular Schwannoma\"\n}\n```\n\n**Explanation:**\n\n1. **Diagnosis:**\n   - The input term \"acoustic neurofibromatosis\" is a synonym for Neurofibromatosis Type 2 (NF2). According to the Target Schema, the standardized term is \"NF2-related schwannomatosis\".\n\n2. **Assay:**\n   - The input term \"RNA-seq with ribosomal RNA depletion\" is a specific type of RNA sequencing. The Target Schema lists \"RNA-seq\" as the standardized term, which encompasses various RNA sequencing methods, including those with ribosomal RNA depletion.\n\n3. **Tumor Type:**\n   - The input term \"Acoustic neuroma of left vestibular nerve\" refers to a vestibular schwannoma. The standardized term in the Target Schema is \"Vestibular Schwannoma\".\n\nThe corrected metadata adheres strictly to the controlled terminology provided in the Target Schema.",
          "model_id": "us.amazon.nova-premier-v1:0",
          "usage": {
            "inputTokens": 2640,
            "outputTokens": 241,
            "totalTokens": 2881
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "bbeca643-6830-4089-8bc4-6ccd38160baa",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 13 Nov 2025 18:44:56 GMT",
                "content-type": "application/json",
                "content-length": "1156",
                "connection": "keep-alive",
                "x-amzn-requestid": "bbeca643-6830-4089-8bc4-6ccd38160baa"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "```json\n{\n  \"diagnosis\": \"NF2-related schwannomatosis\",\n  \"assay\": \"RNA-seq\",\n  \"tumorType\": \"Vestibular Schwannoma\"\n}\n```\n\n**Explanation:**\n\n1. **Diagnosis:**\n   - The input term \"acoustic neurofibromatosis\" is a synonym for Neurofibromatosis Type 2 (NF2). According to the Target Schema, the standardized term is \"NF2-related schwannomatosis\".\n\n2. **Assay:**\n   - The input term \"RNA-seq with ribosomal RNA depletion\" is a specific type of RNA sequencing. The Target Schema lists \"RNA-seq\" as the standardized term, which encompasses various RNA sequencing methods, including those with ribosomal RNA depletion.\n\n3. **Tumor Type:**\n   - The input term \"Acoustic neuroma of left vestibular nerve\" refers to a vestibular schwannoma. The standardized term in the Target Schema is \"Vestibular Schwannoma\".\n\nThe corrected metadata adheres strictly to the controlled terminology provided in the Target Schema."
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2640,
              "outputTokens": 241,
              "totalTokens": 2881
            },
            "metrics": {
              "latencyMs": 4696
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "NF2-related schwannomatosis",
          "assay": "RNA-seq",
          "tumorType": "schwannoma"
        },
        "token_usage": {
          "input_tokens": 2640,
          "output_tokens": 241,
          "total_tokens": 2881
        }
      },
      {
        "sample_index": 9,
        "input": {
          "diagnosis": "neurofibromatosis type 1 due to NF1 mutation or intragenic deletion",
          "assay": "CellTiter-Glo\u00ae 3D Cell Viability Assay",
          "tumorType": "Epithelioid Malignant Peripheral Nerve Sheath Tumor"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Explanation:**\n\n1. **Diagnosis:**\n   - Original: `\"neurofibromatosis type 1 due to NF1 mutation or intragenic deletion\"`\n   - Corrected: `\"Neurofibromatosis type 1\"`\n   - The controlled terminology requires the exact value `\"Neurofibromatosis type 1\"`, ignoring additional details about mutations or deletions.\n\n2. **Assay:**\n   - Original: `\"CellTiter-Glo\u00ae 3D Cell Viability Assay\"`\n   - Corrected: `\"cell viability assay\"`\n   - The closest match in the schema is `\"cell viability assay\"`, as the original term specifies a commercial assay for measuring cell viability.\n\n3. **Tumor Type:**\n   - Original: `\"Epithelioid Malignant Peripheral Nerve Sheath Tumor\"`\n   - Corrected: `\"Malignant Peripheral Nerve Sheath Tumor\"`\n   - The schema includes `\"Malignant Peripheral Nerve Sheath Tumor\"`, which is the broader category for the specified tumor type. The term \"Epithelioid\" is a subtype not listed in the schema, so it is omitted.",
          "model_id": "us.amazon.nova-premier-v1:0",
          "usage": {
            "inputTokens": 2664,
            "outputTokens": 299,
            "totalTokens": 2963
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "8d21b81a-8efa-4cc3-adc1-2b19d265bc8b",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 13 Nov 2025 18:44:59 GMT",
                "content-type": "application/json",
                "content-length": "1349",
                "connection": "keep-alive",
                "x-amzn-requestid": "8d21b81a-8efa-4cc3-adc1-2b19d265bc8b"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Explanation:**\n\n1. **Diagnosis:**\n   - Original: `\"neurofibromatosis type 1 due to NF1 mutation or intragenic deletion\"`\n   - Corrected: `\"Neurofibromatosis type 1\"`\n   - The controlled terminology requires the exact value `\"Neurofibromatosis type 1\"`, ignoring additional details about mutations or deletions.\n\n2. **Assay:**\n   - Original: `\"CellTiter-Glo\u00ae 3D Cell Viability Assay\"`\n   - Corrected: `\"cell viability assay\"`\n   - The closest match in the schema is `\"cell viability assay\"`, as the original term specifies a commercial assay for measuring cell viability.\n\n3. **Tumor Type:**\n   - Original: `\"Epithelioid Malignant Peripheral Nerve Sheath Tumor\"`\n   - Corrected: `\"Malignant Peripheral Nerve Sheath Tumor\"`\n   - The schema includes `\"Malignant Peripheral Nerve Sheath Tumor\"`, which is the broader category for the specified tumor type. The term \"Epithelioid\" is a subtype not listed in the schema, so it is omitted."
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2664,
              "outputTokens": 299,
              "totalTokens": 2963
            },
            "metrics": {
              "latencyMs": 3425
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "3D microtissue viability",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 2664,
          "output_tokens": 299,
          "total_tokens": 2963
        }
      }
    ],
    "metrics": {
      "total_samples": 10,
      "successful_runs": 10,
      "failed_runs": 0,
      "success_rate": 1.0,
      "average_score": 0.8999999999999998,
      "min_score": 0.6666666666666666,
      "max_score": 1.0,
      "num_scored": 10
    },
    "duration_seconds": 34.676814794540405,
    "token_usage": {
      "input_tokens": 26433,
      "output_tokens": 2299,
      "total_tokens": 28732
    }
  }
}